Teresita Bellido
Concepts (470)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 61 | 2023 | 220 | 13.140 |
Why?
| Bone and Bones | 42 | 2023 | 516 | 7.550 |
Why?
| Osteoblasts | 51 | 2022 | 514 | 5.480 |
Why?
| Bone Resorption | 26 | 2023 | 326 | 4.890 |
Why?
| Osteogenesis | 30 | 2022 | 377 | 4.870 |
Why?
| Signal Transduction | 39 | 2022 | 1753 | 4.320 |
Why?
| Parathyroid Hormone | 16 | 2024 | 196 | 4.290 |
Why?
| Bone Remodeling | 21 | 2022 | 177 | 4.070 |
Why?
| Osteoclasts | 32 | 2023 | 469 | 3.910 |
Why?
| Apoptosis | 32 | 2017 | 1300 | 3.300 |
Why?
| Glucocorticoids | 11 | 2019 | 234 | 3.110 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 9 | 2022 | 24 | 3.020 |
Why?
| Osteoporosis | 9 | 2024 | 164 | 2.410 |
Why?
| Mice | 87 | 2024 | 6413 | 2.400 |
Why?
| Animals | 115 | 2024 | 14385 | 2.370 |
Why?
| Receptors, Notch | 5 | 2022 | 28 | 2.260 |
Why?
| Diphosphonates | 9 | 2024 | 96 | 2.200 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 64 | 2.130 |
Why?
| Connexin 43 | 13 | 2017 | 23 | 2.060 |
Why?
| RANK Ligand | 10 | 2018 | 183 | 2.060 |
Why?
| Glycoproteins | 15 | 2019 | 132 | 2.000 |
Why?
| Mechanotransduction, Cellular | 10 | 2016 | 35 | 1.930 |
Why?
| Wnt Signaling Pathway | 10 | 2022 | 94 | 1.910 |
Why?
| Antioxidants | 4 | 2020 | 297 | 1.650 |
Why?
| beta Catenin | 8 | 2022 | 102 | 1.590 |
Why?
| Adaptor Proteins, Signal Transducing | 19 | 2020 | 208 | 1.500 |
Why?
| Bone Density Conservation Agents | 7 | 2024 | 83 | 1.500 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 10 | 2013 | 101 | 1.350 |
Why?
| Bone Density | 20 | 2024 | 416 | 1.290 |
Why?
| Intercellular Signaling Peptides and Proteins | 16 | 2019 | 122 | 1.210 |
Why?
| Osteoporosis, Postmenopausal | 4 | 2024 | 36 | 1.180 |
Why?
| NF-E2-Related Factor 2 | 2 | 2017 | 63 | 1.120 |
Why?
| Teriparatide | 3 | 2024 | 14 | 1.120 |
Why?
| Focal Adhesion Kinase 2 | 3 | 2019 | 12 | 1.110 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 2024 | 202 | 1.110 |
Why?
| Mice, Knockout | 17 | 2022 | 926 | 1.110 |
Why?
| Mice, Inbred C57BL | 20 | 2022 | 1999 | 1.100 |
Why?
| Cells, Cultured | 28 | 2018 | 1737 | 1.090 |
Why?
| Anoikis | 2 | 2019 | 9 | 1.020 |
Why?
| Receptors, Parathyroid Hormone | 3 | 2014 | 11 | 0.950 |
Why?
| Parathyroid Hormone-Related Protein | 2 | 2024 | 24 | 0.820 |
Why?
| Mice, Transgenic | 11 | 2015 | 656 | 0.820 |
Why?
| Cell Differentiation | 11 | 2021 | 720 | 0.820 |
Why?
| Aging | 6 | 2018 | 784 | 0.810 |
Why?
| Bone Marrow | 6 | 2016 | 411 | 0.760 |
Why?
| Fractures, Bone | 3 | 2023 | 119 | 0.760 |
Why?
| Calcitriol | 10 | 2005 | 40 | 0.760 |
Why?
| Weight-Bearing | 6 | 2016 | 56 | 0.740 |
Why?
| Cell Survival | 12 | 2019 | 657 | 0.740 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2023 | 140 | 0.730 |
Why?
| Cell Communication | 3 | 2022 | 72 | 0.720 |
Why?
| Wnt Proteins | 7 | 2013 | 110 | 0.710 |
Why?
| Female | 41 | 2024 | 28441 | 0.700 |
Why?
| Stress, Mechanical | 5 | 2013 | 96 | 0.670 |
Why?
| Alendronate | 7 | 2015 | 20 | 0.660 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 5 | 0.640 |
Why?
| Humans | 61 | 2024 | 54284 | 0.630 |
Why?
| Interleukin-6 | 10 | 1998 | 315 | 0.630 |
Why?
| Bone Marrow Cells | 9 | 2021 | 233 | 0.590 |
Why?
| Adipogenesis | 1 | 2017 | 52 | 0.590 |
Why?
| Collagen Type I | 4 | 2015 | 97 | 0.590 |
Why?
| ortho-Aminobenzoates | 1 | 2016 | 9 | 0.580 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 99 | 0.570 |
Why?
| Muscular Atrophy | 1 | 2017 | 73 | 0.570 |
Why?
| Fracture Healing | 1 | 2016 | 26 | 0.570 |
Why?
| Down-Regulation | 7 | 2017 | 388 | 0.560 |
Why?
| Fibroblast Growth Factors | 3 | 2017 | 59 | 0.560 |
Why?
| Adipocytes | 1 | 2017 | 129 | 0.560 |
Why?
| Cellular Microenvironment | 1 | 2016 | 27 | 0.550 |
Why?
| Organ Size | 6 | 2019 | 237 | 0.540 |
Why?
| Peptides | 4 | 2015 | 276 | 0.530 |
Why?
| Caveolin 1 | 2 | 2013 | 21 | 0.530 |
Why?
| Estrogen Receptor beta | 3 | 2022 | 56 | 0.530 |
Why?
| Extracellular Matrix Proteins | 6 | 2022 | 75 | 0.510 |
Why?
| Models, Biological | 10 | 2016 | 823 | 0.510 |
Why?
| Periosteum | 2 | 2012 | 20 | 0.500 |
Why?
| Mitogen-Activated Protein Kinases | 4 | 2004 | 169 | 0.500 |
Why?
| Genetic Markers | 8 | 2020 | 117 | 0.490 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 4 | 2023 | 7 | 0.490 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 123 | 0.480 |
Why?
| Gap Junctions | 2 | 2017 | 27 | 0.480 |
Why?
| Gene Deletion | 7 | 2019 | 293 | 0.470 |
Why?
| Hematopoietic Stem Cells | 2 | 2012 | 215 | 0.470 |
Why?
| Estrogens | 6 | 2007 | 244 | 0.470 |
Why?
| MAP Kinase Signaling System | 3 | 2012 | 133 | 0.450 |
Why?
| Phosphorylation | 12 | 2014 | 614 | 0.440 |
Why?
| Multiple Myeloma | 5 | 2022 | 3035 | 0.440 |
Why?
| Muscles | 5 | 1993 | 114 | 0.440 |
Why?
| Cell Line | 16 | 2014 | 1153 | 0.440 |
Why?
| Phosphates | 5 | 2016 | 51 | 0.430 |
Why?
| RNA, Messenger | 8 | 2017 | 1202 | 0.410 |
Why?
| Up-Regulation | 7 | 2014 | 508 | 0.410 |
Why?
| Hyperostosis | 2 | 2022 | 4 | 0.410 |
Why?
| Enzyme Inhibitors | 6 | 2014 | 446 | 0.400 |
Why?
| Phosphoproteins | 3 | 2018 | 116 | 0.390 |
Why?
| Gene Expression Regulation | 8 | 2017 | 1062 | 0.380 |
Why?
| Gene Expression | 5 | 2017 | 664 | 0.380 |
Why?
| Enzyme Activation | 9 | 2010 | 329 | 0.380 |
Why?
| Estrogen Receptor alpha | 3 | 2022 | 95 | 0.360 |
Why?
| Focal Adhesion Kinase 1 | 2 | 2007 | 15 | 0.350 |
Why?
| Male | 23 | 2024 | 27334 | 0.350 |
Why?
| X-Ray Microtomography | 6 | 2022 | 82 | 0.340 |
Why?
| Receptors, Estrogen | 6 | 2022 | 131 | 0.340 |
Why?
| MicroRNAs | 3 | 2019 | 386 | 0.330 |
Why?
| src-Family Kinases | 3 | 2005 | 54 | 0.330 |
Why?
| Cytokines | 7 | 2014 | 676 | 0.330 |
Why?
| Cell Membrane | 2 | 2007 | 278 | 0.320 |
Why?
| Monocytes | 1 | 2008 | 156 | 0.300 |
Why?
| Osteolysis | 3 | 2022 | 88 | 0.290 |
Why?
| Membrane Glycoproteins | 5 | 2003 | 269 | 0.290 |
Why?
| Weightlessness | 1 | 2006 | 14 | 0.280 |
Why?
| Osteoprotegerin | 2 | 2016 | 57 | 0.280 |
Why?
| Protein-Tyrosine Kinases | 3 | 2010 | 101 | 0.280 |
Why?
| Calcifediol | 4 | 1991 | 9 | 0.270 |
Why?
| HeLa Cells | 10 | 2017 | 291 | 0.270 |
Why?
| Transcription Factors | 3 | 2004 | 622 | 0.270 |
Why?
| Cell Nucleus | 5 | 2013 | 203 | 0.270 |
Why?
| Dexamethasone | 6 | 2017 | 435 | 0.270 |
Why?
| Integrins | 1 | 2005 | 36 | 0.260 |
Why?
| Caspases | 3 | 2006 | 146 | 0.260 |
Why?
| Skull | 5 | 2015 | 79 | 0.260 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 27 | 0.250 |
Why?
| Caspase 3 | 5 | 2017 | 135 | 0.240 |
Why?
| Multienzyme Complexes | 1 | 2003 | 41 | 0.240 |
Why?
| Antigens, CD | 4 | 2000 | 242 | 0.230 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 75 | 0.230 |
Why?
| Calcium Channels | 2 | 2001 | 59 | 0.230 |
Why?
| Rats | 9 | 2014 | 3415 | 0.230 |
Why?
| Estradiol | 8 | 2007 | 219 | 0.230 |
Why?
| Gingivitis | 1 | 2023 | 2 | 0.230 |
Why?
| Alveolar Bone Loss | 1 | 2023 | 15 | 0.230 |
Why?
| Periodontitis | 1 | 2023 | 10 | 0.230 |
Why?
| Actins | 2 | 2005 | 132 | 0.230 |
Why?
| Kinetics | 8 | 2004 | 692 | 0.220 |
Why?
| Protein Kinases | 2 | 2014 | 89 | 0.220 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 82 | 0.220 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 2016 | 434 | 0.220 |
Why?
| Tuberous Sclerosis | 1 | 2022 | 37 | 0.220 |
Why?
| Absorptiometry, Photon | 3 | 2023 | 174 | 0.210 |
Why?
| Phosphotyrosine | 2 | 1999 | 7 | 0.210 |
Why?
| Tumor Suppressor Proteins | 1 | 2022 | 141 | 0.210 |
Why?
| Transfection | 6 | 2007 | 399 | 0.210 |
Why?
| Disease Models, Animal | 6 | 2021 | 1639 | 0.200 |
Why?
| Bone Matrix | 2 | 2019 | 20 | 0.200 |
Why?
| Receptors, Androgen | 3 | 2006 | 49 | 0.200 |
Why?
| Transcription, Genetic | 7 | 2006 | 418 | 0.190 |
Why?
| Neoplasm Proteins | 1 | 2003 | 359 | 0.190 |
Why?
| Dihydrotestosterone | 3 | 2006 | 14 | 0.190 |
Why?
| Trans-Activators | 3 | 2018 | 147 | 0.190 |
Why?
| Phenotype | 3 | 2020 | 820 | 0.180 |
Why?
| Mutation | 5 | 2023 | 1501 | 0.180 |
Why?
| Dentin | 1 | 2019 | 6 | 0.180 |
Why?
| Calcitonin | 1 | 1999 | 38 | 0.180 |
Why?
| Sex Characteristics | 2 | 2023 | 214 | 0.180 |
Why?
| Phylogeny | 1 | 2020 | 269 | 0.180 |
Why?
| Cell Division | 5 | 2005 | 330 | 0.180 |
Why?
| DNA-Binding Proteins | 3 | 2003 | 462 | 0.180 |
Why?
| Lymphokines | 2 | 1997 | 20 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1476 | 0.180 |
Why?
| Cell Proliferation | 2 | 2016 | 1096 | 0.180 |
Why?
| Ovariectomy | 4 | 2014 | 125 | 0.180 |
Why?
| Growth Inhibitors | 2 | 1997 | 32 | 0.180 |
Why?
| Protein Binding | 4 | 2011 | 736 | 0.170 |
Why?
| Receptors, Interleukin-17 | 1 | 2018 | 2 | 0.170 |
Why?
| Dental Cementum | 1 | 2018 | 1 | 0.170 |
Why?
| Tooth Ankylosis | 1 | 2018 | 1 | 0.170 |
Why?
| Gonadal Steroid Hormones | 3 | 2007 | 42 | 0.170 |
Why?
| Anabolic Agents | 1 | 2019 | 35 | 0.170 |
Why?
| Tretinoin | 1 | 1999 | 56 | 0.170 |
Why?
| Bone Diseases | 2 | 2017 | 109 | 0.170 |
Why?
| Mefloquine | 1 | 2018 | 5 | 0.170 |
Why?
| Cyclins | 1 | 1998 | 54 | 0.170 |
Why?
| Primary Cell Culture | 2 | 2017 | 65 | 0.160 |
Why?
| Chick Embryo | 6 | 2001 | 79 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 673 | 0.160 |
Why?
| Culture Media, Conditioned | 3 | 2023 | 52 | 0.150 |
Why?
| Repressor Proteins | 1 | 2019 | 165 | 0.150 |
Why?
| Femur | 2 | 2015 | 144 | 0.150 |
Why?
| Bone Development | 1 | 2018 | 69 | 0.150 |
Why?
| Nuclear Respiratory Factor 1 | 1 | 2017 | 2 | 0.150 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 16 | 0.150 |
Why?
| Oxidative Stress | 2 | 2017 | 958 | 0.150 |
Why?
| Glucuronidase | 1 | 2017 | 48 | 0.150 |
Why?
| Osteoporotic Fractures | 1 | 2017 | 11 | 0.150 |
Why?
| Mice, 129 Strain | 1 | 2017 | 49 | 0.150 |
Why?
| Hyponatremia | 1 | 2017 | 15 | 0.150 |
Why?
| Calcium | 4 | 2023 | 432 | 0.150 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 124 | 0.150 |
Why?
| Hypophosphatemia, Familial | 1 | 2016 | 1 | 0.140 |
Why?
| Diet | 1 | 2020 | 598 | 0.140 |
Why?
| Immunohistochemistry | 3 | 2017 | 1089 | 0.140 |
Why?
| Cyclin D1 | 1 | 2016 | 60 | 0.140 |
Why?
| Receptors, Interleukin | 1 | 1996 | 11 | 0.140 |
Why?
| Random Allocation | 1 | 2017 | 312 | 0.140 |
Why?
| Receptors, Nerve Growth Factor | 1 | 1996 | 6 | 0.140 |
Why?
| Receptors, Cytokine | 1 | 1996 | 13 | 0.140 |
Why?
| Integrases | 2 | 2022 | 45 | 0.140 |
Why?
| Etoposide | 4 | 2005 | 85 | 0.140 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2010 | 20 | 0.140 |
Why?
| Infant, Newborn | 1 | 2024 | 2907 | 0.140 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 78 | 0.140 |
Why?
| Hindlimb | 1 | 2015 | 25 | 0.130 |
Why?
| Peptide Fragments | 3 | 2015 | 242 | 0.130 |
Why?
| Protein Structure, Tertiary | 4 | 2015 | 289 | 0.130 |
Why?
| Hematopoiesis | 2 | 2014 | 80 | 0.130 |
Why?
| Core Binding Factor Alpha 1 Subunit | 2 | 2006 | 48 | 0.130 |
Why?
| Hindlimb Suspension | 1 | 2015 | 45 | 0.130 |
Why?
| Adiposity | 1 | 2016 | 142 | 0.130 |
Why?
| Mutation, Missense | 1 | 2015 | 117 | 0.130 |
Why?
| Homeostasis | 2 | 2012 | 223 | 0.130 |
Why?
| Time Factors | 7 | 2015 | 3213 | 0.130 |
Why?
| Promoter Regions, Genetic | 3 | 2008 | 520 | 0.130 |
Why?
| Testosterone | 1 | 1995 | 119 | 0.130 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.130 |
Why?
| Receptors, Calcitriol | 3 | 2005 | 21 | 0.120 |
Why?
| Protein Kinase C | 2 | 2003 | 65 | 0.120 |
Why?
| Nucleic Acid Synthesis Inhibitors | 2 | 2005 | 17 | 0.120 |
Why?
| Sirtuin 1 | 1 | 2014 | 29 | 0.120 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 153 | 0.120 |
Why?
| Organ Culture Techniques | 1 | 2014 | 53 | 0.120 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 29 | 0.120 |
Why?
| Lymphoid Tissue | 1 | 1994 | 23 | 0.120 |
Why?
| Myeloproliferative Disorders | 1 | 2014 | 28 | 0.120 |
Why?
| LDL-Receptor Related Proteins | 2 | 2011 | 11 | 0.120 |
Why?
| Receptors, Steroid | 1 | 1993 | 21 | 0.120 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 151 | 0.120 |
Why?
| Transcriptome | 1 | 2016 | 346 | 0.120 |
Why?
| Injections, Subcutaneous | 1 | 2013 | 58 | 0.120 |
Why?
| Blotting, Western | 5 | 2011 | 683 | 0.120 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 66 | 0.120 |
Why?
| Receptor Cross-Talk | 1 | 2013 | 7 | 0.110 |
Why?
| TCF Transcription Factors | 1 | 2013 | 11 | 0.110 |
Why?
| Osteocalcin | 2 | 2014 | 46 | 0.110 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 125 | 0.110 |
Why?
| Hematologic Neoplasms | 1 | 2014 | 99 | 0.110 |
Why?
| Flavonoids | 1 | 2013 | 62 | 0.110 |
Why?
| Ulna | 2 | 2013 | 15 | 0.110 |
Why?
| Protein Transport | 1 | 2013 | 195 | 0.110 |
Why?
| RNA, Small Interfering | 1 | 2013 | 252 | 0.110 |
Why?
| Arrestins | 1 | 2011 | 1 | 0.100 |
Why?
| Flow Cytometry | 2 | 2012 | 546 | 0.100 |
Why?
| Societies, Scientific | 1 | 2011 | 15 | 0.100 |
Why?
| Transgenes | 1 | 2011 | 55 | 0.100 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 165 | 0.100 |
Why?
| Absorption | 1 | 2011 | 24 | 0.100 |
Why?
| Ligands | 3 | 2007 | 230 | 0.100 |
Why?
| Minerals | 1 | 2011 | 36 | 0.100 |
Why?
| Health | 1 | 2011 | 29 | 0.100 |
Why?
| Lumbar Vertebrae | 2 | 2018 | 105 | 0.100 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 176 | 0.100 |
Why?
| Etidronic Acid | 2 | 2001 | 6 | 0.100 |
Why?
| Cytokine Receptor gp130 | 4 | 2000 | 13 | 0.100 |
Why?
| Muscle, Skeletal | 1 | 2017 | 847 | 0.100 |
Why?
| Estrogen Antagonists | 2 | 2007 | 19 | 0.090 |
Why?
| Extracellular Matrix | 1 | 2010 | 111 | 0.090 |
Why?
| Spine | 1 | 2010 | 111 | 0.090 |
Why?
| Hormones | 2 | 2008 | 59 | 0.090 |
Why?
| Dactinomycin | 2 | 2003 | 23 | 0.080 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 110 | 0.080 |
Why?
| Gene Silencing | 1 | 2008 | 129 | 0.080 |
Why?
| Biomedical Research | 1 | 2011 | 240 | 0.080 |
Why?
| Nifedipine | 2 | 2001 | 24 | 0.080 |
Why?
| Molecular Structure | 2 | 2006 | 319 | 0.080 |
Why?
| Base Sequence | 4 | 1998 | 719 | 0.080 |
Why?
| Stem Cells | 2 | 2006 | 193 | 0.080 |
Why?
| Phospholipids | 1 | 1987 | 63 | 0.080 |
Why?
| Estrenes | 2 | 2006 | 12 | 0.080 |
Why?
| Cattle | 1 | 2008 | 224 | 0.080 |
Why?
| Dihydroxycholecalciferols | 1 | 1987 | 3 | 0.080 |
Why?
| Tibia | 1 | 2007 | 117 | 0.080 |
Why?
| bcl-Associated Death Protein | 2 | 2003 | 13 | 0.080 |
Why?
| Weight Gain | 1 | 2008 | 243 | 0.070 |
Why?
| Leukemia Inhibitory Factor | 2 | 1997 | 15 | 0.070 |
Why?
| Genotype | 1 | 2008 | 599 | 0.070 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 56 | 0.070 |
Why?
| Spleen | 1 | 2008 | 186 | 0.070 |
Why?
| Membrane Proteins | 1 | 1989 | 389 | 0.070 |
Why?
| Fatty Acids | 1 | 1987 | 174 | 0.070 |
Why?
| Disease Progression | 2 | 2021 | 913 | 0.070 |
Why?
| Cell Count | 1 | 2006 | 181 | 0.070 |
Why?
| RNA | 2 | 2005 | 202 | 0.070 |
Why?
| Kidney | 1 | 2011 | 820 | 0.070 |
Why?
| Injections | 1 | 2005 | 61 | 0.070 |
Why?
| Caveolae | 1 | 2005 | 7 | 0.070 |
Why?
| Physical Stimulation | 1 | 2005 | 36 | 0.070 |
Why?
| beta-Cyclodextrins | 1 | 2005 | 18 | 0.070 |
Why?
| Tubulin | 1 | 2005 | 28 | 0.070 |
Why?
| src Homology Domains | 2 | 2001 | 9 | 0.070 |
Why?
| Cytoskeleton | 1 | 2005 | 50 | 0.070 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 39 | 0.060 |
Why?
| Cycloheximide | 3 | 2005 | 32 | 0.060 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 8 | 0.060 |
Why?
| Cell Line, Tumor | 2 | 2021 | 1550 | 0.060 |
Why?
| Carrier Proteins | 2 | 2003 | 359 | 0.060 |
Why?
| Drug Administration Schedule | 1 | 2005 | 401 | 0.060 |
Why?
| Drug Synergism | 1 | 2004 | 171 | 0.060 |
Why?
| Receptors, Interleukin-6 | 3 | 2000 | 29 | 0.060 |
Why?
| Binding Sites | 3 | 2012 | 440 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 206 | 0.060 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 32 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 34 | 0.060 |
Why?
| Carcinogens | 1 | 2005 | 231 | 0.060 |
Why?
| CD40 Ligand | 1 | 2003 | 15 | 0.060 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2023 | 1 | 0.060 |
Why?
| Alveolar Process | 1 | 2023 | 14 | 0.060 |
Why?
| NF-kappa B | 2 | 2014 | 335 | 0.060 |
Why?
| DNA | 3 | 2005 | 581 | 0.060 |
Why?
| Models, Genetic | 1 | 2003 | 209 | 0.060 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 131 | 0.050 |
Why?
| Fibroblasts | 2 | 2001 | 386 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 158 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2022 | 82 | 0.050 |
Why?
| Fluorescent Dyes | 1 | 2023 | 116 | 0.050 |
Why?
| Embryo, Mammalian | 1 | 2001 | 68 | 0.050 |
Why?
| Luminescent Proteins | 1 | 2001 | 66 | 0.050 |
Why?
| Clodronic Acid | 1 | 2021 | 20 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2001 | 72 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 255 | 0.050 |
Why?
| STAT3 Transcription Factor | 2 | 2000 | 87 | 0.050 |
Why?
| Interleukin-5 | 1 | 2000 | 6 | 0.050 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 219 | 0.050 |
Why?
| Cell-Free System | 1 | 2000 | 16 | 0.050 |
Why?
| Odontogenesis | 1 | 2019 | 1 | 0.050 |
Why?
| Dental Pulp | 1 | 2019 | 2 | 0.050 |
Why?
| Odontoblasts | 1 | 2019 | 5 | 0.050 |
Why?
| Recombinant Proteins | 2 | 1998 | 569 | 0.040 |
Why?
| In Situ Nick-End Labeling | 1 | 1999 | 64 | 0.040 |
Why?
| Prednisolone | 1 | 1999 | 57 | 0.040 |
Why?
| Semaphorins | 1 | 2019 | 3 | 0.040 |
Why?
| Rifabutin | 1 | 1999 | 5 | 0.040 |
Why?
| Lactams, Macrocyclic | 1 | 1999 | 14 | 0.040 |
Why?
| Isotretinoin | 1 | 1999 | 9 | 0.040 |
Why?
| Quinones | 1 | 1999 | 11 | 0.040 |
Why?
| Benzoquinones | 1 | 1999 | 33 | 0.040 |
Why?
| Periodontal Ligament | 1 | 2018 | 2 | 0.040 |
Why?
| Tooth Eruption | 1 | 2018 | 2 | 0.040 |
Why?
| Transcription Factor AP-1 | 1 | 2019 | 64 | 0.040 |
Why?
| Sodium | 2 | 1991 | 102 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2015 | 84 | 0.040 |
Why?
| Cell Adhesion Molecules | 1 | 1999 | 87 | 0.040 |
Why?
| Biological Transport | 2 | 1991 | 195 | 0.040 |
Why?
| Interleukin-17 | 1 | 2018 | 38 | 0.040 |
Why?
| Oligonucleotides, Antisense | 1 | 1998 | 29 | 0.040 |
Why?
| Cytoplasm | 3 | 2004 | 108 | 0.040 |
Why?
| Growth Substances | 1 | 1998 | 32 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 93 | 0.040 |
Why?
| Inflammation | 1 | 2023 | 674 | 0.040 |
Why?
| Hyperparathyroidism, Primary | 1 | 2018 | 50 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 1999 | 477 | 0.040 |
Why?
| Connective Tissue Cells | 1 | 1997 | 1 | 0.040 |
Why?
| Ciliary Neurotrophic Factor | 1 | 1997 | 11 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 1995 | 980 | 0.040 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 39 | 0.040 |
Why?
| Osteogenesis Imperfecta | 1 | 2018 | 39 | 0.040 |
Why?
| Endometrial Neoplasms | 1 | 1999 | 144 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1997 | 27 | 0.040 |
Why?
| Analysis of Variance | 1 | 1999 | 635 | 0.040 |
Why?
| HMGB1 Protein | 1 | 2017 | 17 | 0.040 |
Why?
| Genetic Complementation Test | 1 | 2017 | 55 | 0.040 |
Why?
| Proto-Oncogene Proteins | 3 | 2005 | 169 | 0.040 |
Why?
| Alkaline Phosphatase | 1 | 1997 | 99 | 0.040 |
Why?
| Body Weight | 1 | 2019 | 578 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 1995 | 197 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 61 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1994 | 47 | 0.040 |
Why?
| Tumor Suppressor Protein p53 | 1 | 1998 | 250 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2018 | 199 | 0.040 |
Why?
| Receptor, Ciliary Neurotrophic Factor | 1 | 1996 | 1 | 0.040 |
Why?
| Receptors, Interleukin-11 | 1 | 1996 | 1 | 0.040 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 1996 | 1 | 0.040 |
Why?
| Receptors, OSM-LIF | 1 | 1996 | 2 | 0.040 |
Why?
| Receptors, Oncostatin M | 1 | 1996 | 2 | 0.040 |
Why?
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1996 | 2 | 0.040 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 30 | 0.030 |
Why?
| Biological Assay | 1 | 1996 | 55 | 0.030 |
Why?
| Gait | 1 | 2017 | 98 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 199 | 0.030 |
Why?
| Accidental Falls | 1 | 2017 | 98 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2015 | 105 | 0.030 |
Why?
| Genetic Loci | 1 | 2015 | 58 | 0.030 |
Why?
| X-Rays | 1 | 2015 | 57 | 0.030 |
Why?
| Orchiectomy | 1 | 1995 | 38 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2015 | 204 | 0.030 |
Why?
| Epigenetic Repression | 1 | 2014 | 1 | 0.030 |
Why?
| Lymphocytes | 1 | 1995 | 168 | 0.030 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 2 | 0.030 |
Why?
| Steroids | 1 | 1995 | 53 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2014 | 10 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 428 | 0.030 |
Why?
| Androgens | 2 | 2007 | 68 | 0.030 |
Why?
| Antigens, Differentiation | 1 | 2014 | 23 | 0.030 |
Why?
| Adjuvants, Immunologic | 1 | 1994 | 61 | 0.030 |
Why?
| Antibodies, Neutralizing | 1 | 2014 | 75 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2014 | 128 | 0.030 |
Why?
| Plasmids | 2 | 2004 | 180 | 0.030 |
Why?
| Bucladesine | 1 | 1993 | 7 | 0.030 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1993 | 10 | 0.030 |
Why?
| Staurosporine | 1 | 1993 | 14 | 0.030 |
Why?
| Diglycerides | 1 | 1993 | 12 | 0.030 |
Why?
| Algorithms | 1 | 2017 | 697 | 0.030 |
Why?
| Body Composition | 1 | 2015 | 349 | 0.030 |
Why?
| Alkaloids | 1 | 1993 | 37 | 0.030 |
Why?
| Transforming Growth Factor beta | 2 | 2006 | 158 | 0.030 |
Why?
| Haversian System | 1 | 2012 | 1 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 562 | 0.030 |
Why?
| Vanadates | 1 | 2012 | 14 | 0.030 |
Why?
| Binding, Competitive | 1 | 2012 | 113 | 0.030 |
Why?
| Heart | 1 | 1994 | 360 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1993 | 531 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1361 | 0.030 |
Why?
| Tissue Distribution | 1 | 2012 | 178 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2011 | 73 | 0.030 |
Why?
| Ion Channels | 1 | 2012 | 75 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2011 | 110 | 0.030 |
Why?
| Spectrometry, X-Ray Emission | 1 | 2011 | 9 | 0.020 |
Why?
| Phosphorus Radioisotopes | 1 | 1991 | 20 | 0.020 |
Why?
| Cholecalciferol | 1 | 1991 | 25 | 0.020 |
Why?
| Rats, Long-Evans | 1 | 2011 | 29 | 0.020 |
Why?
| Microscopy, Electron | 1 | 2011 | 97 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 206 | 0.020 |
Why?
| Rabbits | 1 | 2012 | 425 | 0.020 |
Why?
| Spectrum Analysis, Raman | 1 | 2011 | 68 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2011 | 112 | 0.020 |
Why?
| Motor Activity | 1 | 2011 | 247 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 866 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2014 | 1663 | 0.020 |
Why?
| Physical Exertion | 1 | 2009 | 67 | 0.020 |
Why?
| Leucine | 1 | 1989 | 113 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1300 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 570 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2007 | 82 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2007 | 67 | 0.020 |
Why?
| Risk Factors | 1 | 2017 | 3935 | 0.020 |
Why?
| Weightlessness Simulation | 1 | 2007 | 23 | 0.020 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 3 | 0.020 |
Why?
| Smad Proteins | 1 | 2006 | 13 | 0.020 |
Why?
| Response Elements | 1 | 2006 | 32 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2006 | 51 | 0.020 |
Why?
| Chickens | 1 | 1987 | 118 | 0.020 |
Why?
| Vitamin D Deficiency | 1 | 1987 | 53 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 8 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 12 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 20 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 13 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 100 | 0.020 |
Why?
| Cholera Toxin | 1 | 2004 | 16 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2005 | 34 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 45 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 55 | 0.020 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 46 | 0.020 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 12 | 0.020 |
Why?
| Caspase Inhibitors | 1 | 2003 | 31 | 0.020 |
Why?
| Tensile Strength | 1 | 2003 | 33 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 4 | 0.010 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 6 | 0.010 |
Why?
| Phosphotransferases | 1 | 2003 | 24 | 0.010 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 25 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 65 | 0.010 |
Why?
| Genes, Reporter | 1 | 2003 | 98 | 0.010 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 83 | 0.010 |
Why?
| Oncostatin M | 1 | 2000 | 5 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 52 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2001 | 134 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 767 | 0.010 |
Why?
| Stromal Cells | 1 | 1997 | 79 | 0.010 |
Why?
| Proto-Oncogene Proteins c-rel | 1 | 1995 | 5 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1995 | 30 | 0.010 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 10 | 0.010 |
Why?
| Myocardium | 1 | 1994 | 441 | 0.010 |
Why?
| Adult | 1 | 1995 | 14207 | 0.000 |
Why?
|
|
Bellido's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|